Effectiveness and Safety of Riociguat as First-line or Combination Therapy in Pulmonary Arterial Hypertension (PAH): A Riociguat Users (ROAR) Registry Analysis Meeting Abstract

Industry Collaboration

cited authors

  • White, R.; Aranda, A. U.; Chakinala, M. M.; Mandras, S.; Mcconnell, J. W.; Miller, C. E.; Sulica, R.; Johnson, D.; Carvajal, V.; Bansilal, S.; Kirkwold, J.; Kim, N. H.

Publication Date

  • May 1, 2023

webpage

category

volume

  • 207